Abstract
Whether the reduction of heart rate with ivabradine (IVA) could affect sympathetic activation and cardiac innervation in heart failure (HF) remains unknown. The present study assessed the chronic effects of IVA and β-blocker on the systemic and local sympathetic nervous systems of hypertensive animals with HF. The Dahl salt-sensitive rats received chronic IVA, bisoprolol (BIS), or placebo (CTL) therapy. The survival of the animal models with IVA and BIS significantly improved (median; 19.7 in IVA and 19.7 in BIS vs 17.0 weeks in CTL, P < .001). A similar decrease in 24-hour heart rate (mean; 305 in IVA and 329 in BIS vs 388 beats/min in CTL, P < .001) without effect on blood pressure, and an improvement in the left ventricular dysfunction (mean fractional shortening; 56.7% in IVA and 47.8% in BIS vs 39.0% in CTL, P < .001) were observed in the animals with IVA and BIS. However, a negative inotropic effect was only observed in the animals with BIS. Excessive urinary noradrenaline excretion in animals with CTL was only suppressed with the use of IVA (mean; 1.35 μg/d in IVA and 1.95 μg/d in BIS vs 2.27 μg/d in CTL, P = .002). In contrast, atrial noradrenaline and acetylcholine depletion in the animals with CTL improved and the tyr...Continue Reading
References
Oct 1, 1984·Journal of the American College of Cardiology·S D ColanA Neumann
Jun 29, 2002·The American Journal of Cardiology·Kenneth C BilchickRonald D Berger
Jan 31, 2004·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Linley E WatsonDavid E Dostal
Aug 11, 2004·Drugs·Dario DiFrancesco, John A Camm
Sep 29, 2006·Basic Research in Cardiology·Adam B SteinBuddhadeb Dawn
Dec 19, 2006·Journal of Cardiac Failure·Philip B Adamson, Edward M Gilbert
Dec 6, 2007·Drugs·Dario DiFrancesco, Jeffrey S Borer
Mar 4, 2008·Cardiovascular Research·Michał Maczewski, Urszula Mackiewicz
Jul 25, 2009·Journal of the American College of Cardiology·John S Floras
Aug 31, 2010·Lancet·Michael BöhmUNKNOWN SHIFT Investigators
Aug 9, 2011·European Heart Journal·Stephan H SchirmerUlrich Laufs
Nov 15, 2011·Journal of Cardiovascular Pharmacology·Yuehua FangChristian Thuillez
Apr 12, 2012·Hypertension·Yonggang MaMerry L Lindsey
Jun 5, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Shekhar H DeoPaul J Fadel
Jul 27, 2012·European Heart Journal·Jan-Christian ReilMichael Böhm
Dec 3, 2013·Frontiers in Physiology·Vincenzo Barrese, Maurizio Taglialatela
Apr 15, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Shuji ShimizuMasaru Sugimachi
Oct 29, 2014·Hypertension·Mario RienzoBijan Ghaleh
Jan 16, 2015·Basic Research in Cardiology·Sabine GentGerd Heusch
Mar 25, 2015·European Journal of Heart Failure·Michael BöhmKarl Swedberg
Jun 16, 2015·British Journal of Pharmacology·P KleinbongardG Heusch
Dec 4, 2015·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Heitaro WatanabeShunichi Miyazaki
Jan 15, 2016·Journal of the American Heart Association·Karsten HeusserJens Jordan
Apr 5, 2016·Drugs·Gerd Heusch, Petra Kleinbongard
Aug 11, 2016·Frontiers in Physiology·Fernanda C SilvaDeoclécio A Chianca
Jun 20, 2017·European Journal of Heart Failure·Aleksandra Nikolovska VukadinovićMichael Böhm
Mar 7, 2018·International Journal of Cardiology·Hiromi YamamotoMasaru Sugimachi